XOMA (NASDAQ:XOMA)

View All ReportsStreetInsider.com Reports on XOMA

Nov 18, 2009 10:55 AM Notable Analyst Rating Changes 11/18: SII, ZMH, FSLR, PHM Upgraded; TGT, ADSK, VIP, JEC, PARD Downgraded

Nov 18, 2009 09:28 AM Canaccord Adams Initiates Coverage on XOMA (XOMA) with a Buy; XOMA-052 Promising New Type 2 Diabetes Drug

Nov 9, 2009 04:54 PM XOMA (XOMA) Falls Modestly Following After-Hours Downgrade

Nov 9, 2009 08:21 AM XOMA (XOMA) Posts Q3 EPS of $0.01, Misses by 1c

Nov 6, 2009 01:29 PM Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report

View All Press ReleasesCompany Press Releases on XOMA

Nov 19, 2009 04:09PM XOMA Receives NASDAQ Determination Letter

Nov 17, 2009 08:00AM XOMA Appoints Jim Neal Vice President of Business Development

Nov 12, 2009 03:17PM XOMA 052 Selected as a Top Ten Project to Watch

Nov 11, 2009 02:30PM XOMA Announces Presentation at Lazard Healthcare Conference on November 18

Nov 9, 2009 08:00AM XOMA Reports 2009 Third Quarter Financial Results

StreetInsider Reports on XOMA by Category

• Analyst Ratings
• Mergers and Acquisitions
• Earnings
• Guidance
• Stock Buybacks
• Dividends
• Retail Sales
• Management Changes
• Insider Trades
• View More Categories

View All BlogsBlogs on XOMA

Nov 9, 2009 01:19 PM XOMA Ltd. Q3 2009 Earnings Call Transcript

Sep 9, 2009 04:29 PM Closing Update for Wednesday, Sept. 9

Aug 7, 2009 07:05 AM XOMA Ltd. Q2 2009 Earnings Call Transcript

Jun 5, 2009 02:50 PM Friday's BioPlay: Xoma Ltd.

May 15, 2009 07:33 AM Upcoming FDA Decisions and Clinical Trials: Prevacid Goes OTC, Swine Flu Test

View All FilingsSEC Filings on XOMA

Nov 19, 2009 04:31PM Form 8-K XOMA LTD /DE/ For: Nov 13

Nov 9, 2009 03:44PM Form 10-Q XOMA LTD /DE/ For: Sep 30

Sep 25, 2009 06:16AM Form 8-K XOMA LTD /DE/ For: Sep 24

View All Comments Comments on recent XOMA articles

Michael
on Nov 12, 2009
at 07:54 PM Monoclonal Antibodies for Type 2 Diabetes I will be retiring early, thanks to XOMA. What's even better, if I contract Diabetes Type II when I reach 60, being a little overweight, I will live a long life without the need for daily insulin injections. XOMA 052 will change the treatment of all forms of diabetes, as we know it.
Article: XOMA (XOMA) Falls Modestly Following After-Hours Downgrade

BioInvestor
on Nov 10, 2009
at 09:20 AM The Diabetes Market Outlook A once monthly or even every 3 month, tiny shot to control blood-sugar in Diabetes Type I & II patients. Are you kidding me, this company is a steal at this price. The upside is well into the $55 range with big pharma serving up daily insulin shots over the last 10yrs. Unbelievable cheap stock will take care of my retirement.
Article: XOMA (XOMA) Posts Q3 EPS of $0.01, Misses by 1c

Francesco
on Nov 9, 2009
at 12:32 PM some hope I waited patiantly for 20 years since I purchessed Xoma at 15.75, I hope the good news will drive the stock up....
Article: XOMA (XOMA) Posts Q3 EPS of $0.01, Misses by 1c

Michael M
on Nov 3, 2009
at 11:31 AM XOMA is a great company. They haven't announced their new patent, but I think this week it will come and the new military applications of an injectable biodefense delivery for military applications. $$ Title: Method of treating or preventing an IL-1 related disease or condition Patent ID: US7582742 Issue Date: September 01, 2009 !!!!!! :) Assignee: XOMA Technology Ltd. (Berkeley, CA)
Article: XOMA (XOMA) and Kaketsuken Enter Into Collaboration for Antibody Research and Development Technologies

Michael
on Oct 14, 2009
at 10:32 AM mbmalone_2000@yahoo.com Type 2 diabetes patients have long sought improved treatment options that go beyond glucose management and frequent insulin injections. Current approaches force more insulin out of 'tired' pancreatic beta cells or make peripheral cells more sensitive to insulin, whereas XOMA 052 targets the actual inflammation mechanism. Showing an increase in insulin production three months after a single infusion is remarkable, we could have a disease-modifying therapy in a single dose of XOMA 052 with positive biological activity and duration of effect ... and it's well tolerated. ZOMA has a blockbuster drug and Engel's knows it!
Article: XOMA Appoints Susan Kramer, Dr. P.H. Vice President of Project and Alliance Management

Comments on XOMA

No comments are currently available.

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?